doxazosin has been researched along with Adenocarcinoma Of Kidney in 2 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two cell lines were used: renal cell carcinoma (RCC) 786-0, harboring a von Hippel-Lindau (VHL) tumor-suppressor gene mutation with a highly angiogenic phenotype, and Caki cells (no VHL mutation)." | 1.37 | Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma. ( Kyprianou, N; Sakamoto, S; Schwarze, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakamoto, S | 1 |
| Schwarze, S | 1 |
| Kyprianou, N | 1 |
| Johansson, M | 1 |
2 other studies available for doxazosin and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma.
Topics: Adrenergic alpha-1 Receptor Antagonists; Anoikis; Antineoplastic Agents; Carcinoma, Renal Cell; Casp | 2011 |
Lord of the rings: a promising novel treatment for renal cell carcinoma?
Topics: Adrenergic alpha-1 Receptor Antagonists; Anoikis; Antineoplastic Agents; Carcinoma, Renal Cell; Cell | 2011 |